Increased MiR-338-3p Expression Correlates with Invasiveness of GH-producing Pituitary Adenomas

Overview

Journal Endocrine

Specialty Endocrinology

Date 2017 Aug 16

PMID 28808880

Citations 14

Authors

Yang Jong Lee

Jin Mo Cho

Ju Hyung Moon

Cheol Ryong Ku

Jean Kim

Sun Ho Kim

Eun Jig Lee

Affiliations

Soon will be listed here.

Citing Articles

Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways.

Serioli S, Agostini L, Pietrantoni A, Valeri F, Costanza F, Chiloiro S Int J Mol Sci. 2023; 24(21).

PMID: 37958702 PMC: 10650665. DOI: 10.3390/ijms242115719.

Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine.

Kim K, Ku C, Lee E Endocrinol Metab (Seoul). 2023; 38(5):463-471.

PMID: 37828709 PMC: 10613768. DOI: 10.3803/EnM.2023.1820.

Plasma Extracellular Vesicle MicroRNA Analysis of Alzheimer's Disease Reveals Dysfunction of a Neural Correlation Network.

Sun Y, Hefu Z, Li B, Lifang W, Zhijie S, Zhou L Research (Wash D C). 2023; 6:0114.

PMID: 37223486 PMC: 10202186. DOI: 10.34133/research.0114.

Exosomal RNAs in the development and treatment of pituitary adenomas.

Chang M, Jiang S, Guo X, Gao J, Liu P, Bao X Front Endocrinol (Lausanne). 2023; 14:1142494.

PMID: 36875488 PMC: 9981947. DOI: 10.3389/fendo.2023.1142494.

Genetic and Epigenetic Pathogenesis of Acromegaly.

Yamamoto M, Takahashi Y Cancers (Basel). 2022; 14(16).

PMID: 36010855 PMC: 9405703. DOI: 10.3390/cancers14163861.

References

Romero D, Plonczynski M, Carvajal C, Gomez-Sanchez E, Gomez-Sanchez C . Microribonucleic acid-21 increases aldosterone secretion and proliferation in H295R human adrenocortical cells. Endocrinology. 2008; 149(5):2477-83. PMC: 2329274. DOI: 10.1210/en.2007-1686. View

Li X, Wang E, Zhou H, Yoshimoto K, Qian Z . MicroRNAs in Human Pituitary Adenomas. Int J Endocrinol. 2014; 2014:435171. PMC: 4274667. DOI: 10.1155/2014/435171. View

Zhang G, Zhao Q, Yu S, Lin R, Yi X . Pttg1 inhibits TGFβ signaling in breast cancer cells to promote their growth. Tumour Biol. 2014; 36(1):199-203. DOI: 10.1007/s13277-014-2609-2. View

Zhang E, Liu S, Xu Z, Huang S, Tan X, Sun C . Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells. Tumour Biol. 2014; 35(9):8801-11. DOI: 10.1007/s13277-014-2143-2. View

Voorhoeve P . MicroRNAs: Oncogenes, tumor suppressors or master regulators of cancer heterogeneity?. Biochim Biophys Acta. 2009; 1805(1):72-86. DOI: 10.1016/j.bbcan.2009.09.003. View

Volinia S, Calin G, Liu C, Ambs S, Cimmino A, Petrocca F . A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006; 103(7):2257-61. PMC: 1413718. DOI: 10.1073/pnas.0510565103. View

Zatelli M, Degli Uberti E . MicroRNAs and possible role in pituitary adenoma. Semin Reprod Med. 2008; 26(6):453-60. DOI: 10.1055/s-0028-1096125. View

Sivapragasam M, Rotondo F, Lloyd R, Scheithauer B, Cusimano M, Syro L . MicroRNAs in the human pituitary. Endocr Pathol. 2011; 22(3):134-43. DOI: 10.1007/s12022-011-9167-6. View

Trivellin G, Butz H, Delhove J, Igreja S, Chahal H, Zivkovic V . MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro. Am J Physiol Endocrinol Metab. 2012; 303(6):E708-19. DOI: 10.1152/ajpendo.00546.2011. View

10.

Caramuta S, Egyhazi S, Rodolfo M, Witten D, Hansson J, Larsson C . MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J Invest Dermatol. 2010; 130(8):2062-70. DOI: 10.1038/jid.2010.63. View

11.

Guo B, Liu L, Yao J, Ma R, Chang D, Li Z . miR-338-3p suppresses gastric cancer progression through a PTEN-AKT axis by targeting P-REX2a. Mol Cancer Res. 2013; 12(3):313-21. DOI: 10.1158/1541-7786.MCR-13-0507. View

12.

Huang X, Wang Q, Chen J, Fu X, Chen X, Chen L . Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. Hepatol Res. 2009; 39(8):786-94. DOI: 10.1111/j.1872-034X.2009.00502.x. View

13.

Zhang X, Horwitz G, Heaney A, Nakashima M, Prezant T, Bronstein M . Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab. 1999; 84(2):761-7. DOI: 10.1210/jcem.84.2.5432. View

14.

Rostad S . Pituitary adenoma pathogenesis: an update. Curr Opin Endocrinol Diabetes Obes. 2012; 19(4):322-7. DOI: 10.1097/MED.0b013e328354b2e2. View

15.

Palumbo T, Faucz F, Azevedo M, Xekouki P, Iliopoulos D, Stratakis C . Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway. Oncogene. 2012; 32(13):1651-9. PMC: 4034118. DOI: 10.1038/onc.2012.190. View

16.

Kong B, Im S, Lee Y, Cho Y, Do Y, Byun J . Vasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs Inflammation. PLoS One. 2016; 11(3):e0149394. PMC: 4803227. DOI: 10.1371/journal.pone.0149394. View

17.

Asa S, Ezzat S . The pathogenesis of pituitary tumours. Nat Rev Cancer. 2002; 2(11):836-49. DOI: 10.1038/nrc926. View

18.

Sonnenschein C, Posner M, Sahr K, Farookhi R, Brunelle R . Estrogen sensitive cell lines: establishment and characterization of new cell lines from estrogen-induced rat pituitary tumors. Exp Cell Res. 1974; 84(1):399-411. DOI: 10.1016/0014-4827(74)90422-4. View

19.

Garzon R, Calin G, Croce C . MicroRNAs in Cancer. Annu Rev Med. 2009; 60:167-79. DOI: 10.1146/annurev.med.59.053006.104707. View